AzTrials
AzTrials

Palliative CareNCT04708002

Interventional Research With Mixed Methods on an Early Integrated Palliative Approach in Nursing Home

A study testing early integrated palliative approach model in people with Palliative Care and Nursing Homes, run by Maison Médicale Jeanne Garnier at 3 sites in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The national context of the end of life of elderly people living in Nursing Home (NH) is concerning. A quarter of NH residents die each year representing a quarter of annual deaths in France of all ages. The number of resident deaths arises (148,300 deaths in 2015 versus 124,500 in 2011). Read more about this study

Who is it for?
Ages 60 years and older
Conditions the study is for
Palliative Care, Nursing Homes, Aged
What is being tested?
early integrated palliative approach model
Could I receive a placebo?
No, everyone receives an active treatment
How many people
3,500 participants
Where
3 sitesFrance
Study dates
30 Mar 2021to 31 Aug 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Be a resident of a nursing home.
  • Be 60 years of age or older.
  • Be a resident who has been identified by the Proactive identification Guidance

Who cannot join

  • Be under 60 years of age.
  • Resident living temporarily in the nursing home.
  • Refusing to participate

Trial locations and contacts

3 sites in 1 country.

Nathalie Bouscaren, PhD contact

003314922189

nbouscaren@adc.asso.fr

Célia Broussard, PhD contact

003314922189

cbroussard@adc.asso.fr

France3 sites, 3 recruiting
  • Ch Avignon

    Avignon

    Sylvie Barois, 0033 1 43 92 21 89, sbarois@adc.asso.fr

    Recruiting
  • Maison de Santé Marie Galène

    Bordeaux

    Morgan Brunet, 0033 1 43 92 21 89, mbrunet@adc.asso.fr

    Recruiting
  • Maison Médicale Jeanne Garnier

    Paris

    Simon Martine, 0033 1 43 92 21 89, smartine@adc.asso.fr

    Recruiting

Other trials in France

About this study

Official title: How to Improve the Care of Elderly People From Nursing Home: Interventional Research With Mixed Methods on an Early Integrated Palliative Approach

The national context of the end of life of elderly people living in Nursing Home (NH) is concerning.

A quarter of NH residents die each year representing a quarter of annual deaths in France of all ages. The number of resident deaths arises (148,300 deaths in 2015 versus 124,500 in 2011). In fact, the age of residents welcomed in NH increase, 82% of residents are 80 years old and over, suffering from several chronic pathologies, some of which are serious and incurable. These are the main cause of death for residents. The advancing age of NH residents and the interweaving of multiple chronic conditions and disabling pathologies generate complex care needs, the complexity of which undermines the current system of care organization. In 2016, 59% of NH residents were severely dependent in their activities of daily living (ADL) and instrumental activities of daily living (IADL) according to the French scale Autonomie, Gérontologie Groupe Iso Ressources, (1 the most dependant to 6 the less dependent); the majority of these most dependent NH residents (80% of Groupe Iso-Ressource 1-2 in 2011) had at least one unstable chronic pathology and 73% of deceased residents (in 2015) come from this group whose level of dependence is very high.

Read more

Palliative care (PC), which is care focused on maintaining quality of life in a context of incurable and complex pathology, therefore appears to be indicated in the context of NH. However, residents' access to PC remains limited, uneven and late. The number of residents requiring this support is estimated at more than 100,000 residents per year. The consequences of such situation are serious, first with regard to the quality of life of NH residents and their family caregivers, but also the inappropriate use of health services (as shown by the excessive use of emergency department and unscheduled hospitalizations) and work life for care providers in NH is affected (care providers suffer from a lack of support when faced with the difficulties of caring for NH residents at the end of their life). However, these consequences are potentially avoidable by means of adapted organizational solutions. The implementation of an integrated and early palliative approach (IEPA) in care pathway of patient is one of the solutions recommended by the World Health Organization and the French National Authority for Health. Several studies have shown the benefit of such approach in the management of cancer patients. However, the transferability and effectiveness of this approach in other organizational and population contexts are poorly documented, particularly in NH settings.

The main objective is to evaluate, through a pragmatic controlled trial the effectiveness of an Early Integrated Palliative Care Approach in usual NH context (EIPCA-NH) on the quality of care in NH for elderly in need of PC. The secondary objectives concern:

  1. the implementation process of the EIPCA-NH: i) measure the degree of implementation of the EIPCA-NH in each site, ii) identify and understand the factors (individual and organizational) facilitating or limiting the success of the implementation process of an IEPA according to NH contexts (inter-site comparison).
  2. the effects of the EIPCA-NH in the NH : i) on the quality of life of residents requiring PC and ii) that of their family caregivers, iii) on the quality work life of professional caregivers and iv) on the care pathway of NH residents.

A mixed methods research, with qualitative and quantitative approach, will be carried out in at least 20 NH in three different health territories. These NH will benefit from a EIPCA-NH intervention which consists of 1) implementing a mechanism for sharing and co-producing knowledge, 2) integrating this approach as early as possible in the care of residents. This study is based on a multicenter, randomized crossover cluster-type stepped-wedge study, running on 4 years in order to measure the sustainability of EIPCA-NH; the quantitative analysis of the effectiveness of EIPCA-NH will focus on an open cohort of 3,500 residents receiving the intervention. The qualitative component will consist of a multiple case study to analyse the process of implementation and production of the EIPCA-NH. The integrative analysis of qualitative and quantitative data will allow a better understanding of the causal mechanisms of the observed phenomena.

This project will provide evidence on the value of EIPCA and the conditions for its implementation and transferability. The proposed intervention will help improve care practices for all NH residents (600,000 people). The approach by co-construction between actors of the thousands of care structures (NH, cities, hospitals) and researchers should promote a better representation of PC, promote the culture of anticipation, evaluation and collaboration between actors of in- and out- NH, contributing to a better synergy of intersectoral and territorial actions of the supply of health services.

Being tested
early integrated palliative approach model
Keywords
Integrated and early palliative care approach, care pathway, quality of care, intervention research, resident, nursing home caregiver, health services research, mixed method

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • early integrated palliative approach modelOther

    From the construction of a common vision of palliative care between actors inside and outside the nursing home to the sustainability of palliative care in nursing home.

Study groups in NCT04708002
Study groupRoleWhat they receive
First EIPCA-NH groupOtherThere are 5 nursing home in each arm (cluster), randomly selected from 3 French areas.
Receives: Other: early integrated palliative approach model
Early intermediate EIPCA-NH groupOtherThere are 5 nursing home in each arm (cluster), randomly selected from 3 French areas.
Receives: Other: early integrated palliative approach model
Late intermediate EIPCA-NH groupOtherThere are 5 nursing home in each arm (cluster), randomly selected from 3 French areas.
Receives: Other: early integrated palliative approach model
Last EIPCA-NH groupOtherThere are 5 nursing home in each arm (cluster), randomly selected from 3 French areas.
Receives: Other: early integrated palliative approach model

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in the number of resident with access to palliative care assessed by the proactive identification guidance and by the InterRAI Palliative Care assessment system

    stepped-wedge with 4 clusters

    Measured: Quantitative data will be collected throughout study completion (up to 2 years), each nursing home will have evaluations following a stepped-wedge design with 4 time periods: Pre-implantation, Implantation, Post implantation, Sustainability

Secondary outcomes (4)
  1. Median score of the degree of implementation using a scale based on Proctor et al indicators, with a minimum score of 6 and a maximum score of 30.

    stepped-wedge with 4 clusters : The minimum score is 6 which means that the degree of implementation is very low. The maximum score is 30 which means that the degree of implementation is very high.

    Measured: Qualitative data collections will be carry out continuously throughout study completion (up to 2 years)

  2. Median score of quality of life of nursing home resident using InterRAI Self-Report Nursing Home Quality of Life Survey instrument (interRAI-QoL)

    stepped-wedge with 4 clusters : InterRAI quality of life has ten subscales with minimum score of 0 and a maximum score ranging between 16 to 24. The minimum score (0) is the best outcome for quality of life and, the maximum (16-24) is the worse outcome.

    Measured: Quantitative data collections will be done throughout study completion (up to 2 years), each nursing home will have one evaluation following a stepped-wedge design with 2 time periods: Pre-implantation, Post implantation

  3. Median score of quality of life of informal caregiver using the Caregiver's Burden Scale in End-of-Life Care (CBS-EOLC) self-questionnaire

    stepped-wedge with 4 clusters : The minimum score is 16 meaning that it is the best outcome for the quality of life of informal caregivers and, the maximum score is 54 meaning that it is the worst outcome.

    Measured: Quantitative data collections will be done throughout study completion (up to 2 years), each nursing home will have one evaluation following a stepped-wedge design with 2 time periods: Pre-implantation, Post implantation

  4. Median score of quality of life of professional caregiver using the professional quality of life scale (ProQoL)

    stepped-wedge with 4 clusters : The minimum score is 30, the average score is around 50 and the highest score is 57 or over. The highest score means a good quality of life of professional caregiver and the lowest score means a poor professional caregiver's quality of life

    Measured: Quantitative data collections will be done throughout study completion (up to 2 years), each nursing home will have one evaluation following a stepped-wedge design with 2 time periods: Pre-implantation, Post implantation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jan 2021
  2. Study start30 Mar 2021
  3. Primary completion30 Mar 2021
  4. Study completion31 Aug 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Model description
stepped-wedge design
Masking
None (open label)
Enrolment
3,500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04708002
Sponsor's protocol ID
2020-A01832-37
Status last verified
Jan 2021
First submitted
3 Dec 2020
Last updated
7 Jun 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Publications

  • Umubyeyi B, Leboul D, Bagaragaza E. "You close the door, wipe your sadness and put on a smiling face": a qualitative study of the emotional labour of healthcare professionals providing palliative care in nursing homes in France. BMC Health Serv Res. 2024 Sep 16;24(1):1070. doi: 10.1186/s12913-024-11550-7.

    PubMed 39278920
  • Bagaragaza E, Colombet I, Perineau M, Aegerter P, Guirimand F. Assessing the implementation and effectiveness of early integrated palliative care in long-term care facilities in France: an interventional mixed-methods study protocol. BMC Palliat Care. 2023 Apr 6;22(1):35. doi: 10.1186/s12904-023-01157-w.

    PubMed 37024830

Questions about this trial

What is this clinical trial studying?

A study testing early integrated palliative approach model in people with Palliative Care and Nursing Homes, run by Maison Médicale Jeanne Garnier at 3 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 7 Jun 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Nathalie Bouscaren, PhD (003314922189, nbouscaren@adc.asso.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in the number of resident with access to palliative care assessed by the proactive identification guidance and by the InterRAI Palliative Care assessment system (time frame: Quantitative data will be collected throughout study completion (up to 2 years), each nursing home will have evaluations following a stepped-wedge design with 4 time periods: Pre-implantation, Implantation, Post implantation, Sustainability). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04708002, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jun 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in